| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V74605 | (Asp28)-Exenatide | 1678417-24-7 | (Asp28)-Exenatide is a degradation product of exenatide. |
|
V79872 | (R)-V-0219 | 3031984-80-9 | (R)-V-0219 is the enantiomer of V-0219. |
|
V77370 | (R)-V-0219 hydrochloride | (R)-V-0219 HCl is the enantiomer of V-0219. | |
|
V79873 | (S)-V-0219 | 3031984-78-5 | (S)-V-0219 is the enantiomer of V-0219. |
|
V77355 | (S)-V-0219 hydrochloride | (S)-V-0219 HCl is the enantiomer of V-0219. | |
|
V128202 | Acmopatide | 2377239-31-9 | Acmopatide is a dual-acting GIP/GLP-1 receptor agonist. |
|
V128402 | AGFAGDDAPR | 330204-04-1 | AGFAGDDAPR is a bioactive peptide that is a competitive, orally effective inhibitor of dipeptidyl peptidase-IV (DPP-IV). |
|
V74603 | Albiglutide fragment (GLP-1-Gly8; GLP-1 (7-36) analog) | 224638-84-0 | Albiglutide fragment (GLP-1 (7-36) analog) is the active fragment (7-36) of Albiglutide and a glucagon-like peptide-1 (GLP-1) analog (a long-acting GLP-1 receptor body agonist). |
|
V96729 | Aleniglipron | 2685823-26-9 | Aleniglipron (Compound 121a) is a GLP-1 agonist with an EC50 value of less than 0.1 nM in a cAMP stimulation assay in HDB cell lines. |
|
V129205 | Anvoglutide | 3091730-40-1 | Anvoglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist with anti-diabetic and anti-obesity effects. |
|
V77247 | Apraglutide TFA (FE 203799 TFA) | Apraglutide TFA (FE 203799 TFA) is a synthetic 33-amino acid (AA) peptide and long-acting GLP-2 analog that enhances adaptability and linear intestinal growth in total ileal resection piglets with neonatal short bowel syndrome. | |
|
V129547 | Astepatide | 2959444-13-2 | Astepatide is a gastric inhibitory peptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist that can be used in antidiabetic research. |
|
V96628 | Exendin(9-39) amide acetate | 2051593-46-3 | Exenatide (9-39) amide acetate is a glucagon-like peptide-1 (GLP-1) antagonist that competes with endogenous GLP-1 for binding to the GLP-1 receptor, thereby counteracting the effects of excess GLP-1 secretion. |
|
V74585 | Bamadutide (SAR425899) | 1596343-09-7 | Bamadutide (SAR425899) is a potent dual glucagon-like peptide-1 receptor/glucagon receptor agonist. |
|
V130066 | Berobenatide | 3028974-74-2 | Berobenatide is a glucagon-like peptide-1 (GLP-1) receptor agonist. |
|
V99916 | Bofanglutidum | 2668298-70-0 | Bofanglutidum is a glucagon-like peptide-1 (GLP-1) receptor agonist. |
|
V130646 | Brenipatide | 2408921-49-1 | Brenipatide is a dual glucagon-like peptide-1 (GLP-1) and gastric inhibitory peptide (GIP) receptor agonist. |
|
V131076 | Carmegliptin hydrochloride | 813452-14-1 | Carmegliptin hydrochloride is an orally effective and potent DPP-IV inhibitor with an IC50 value of 6.8 nM for human DPP-IV. |
|
V108942 | CHU-128 | 2212020-93-2 | CHU-128 is a potent and selective GLP-1 receptor agonist. |
|
V74604 | Cinnamtannin A2 (cinnamon tannin A2) | 86631-38-1 | Cinnamtannin A2 is a tetrameric proanthocyanidin that increases GLP-1 and insulin secretion in mice. |
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
